<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":3244,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
In re Baxter Int'l, Inc., 678 F.3d 1357, 102 U.S.P.Q.2d 1925 (Fed. Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/f5e429a1cda65302a0d16c1e6b109ae0'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/f5e429a1cda65302a0d16c1e6b109ae0'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1HO4TO003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HO4TO003">Previous Result: <span>Lehman v. Lucom, No. Case No.: 11-23479-...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1HO4U2003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HO4U2003">Next Result: <span>Perez-Urena v. United States, CRIMINAL A...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='In re Baxter Int&amp;#x27;l, Inc., 678 F.3d 1357, 102 U.S.P.Q.2d 1925 (Fed. Cir. 2012), Court Opinion'>
In re Baxter Int&#x27;l, Inc., 678 F.3d 1357, 102 U.S.P.Q.2d 1925 (Fed. Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>In re Baxter Int'l, Inc., 678 F.3d 1357, 102 U.S.P.Q.2d 1925 (Fed. Cir. 2012), Court Opinion</div>
<div class='docId'>X1HO420003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>In re Baxter Int'l, Inc.</div>
<div class='displayCitation'>102 U.S.P.Q.2d 1925</div>
<div class='displayCitation'>2012 BL 121025</div>
<div class='displayCitation'>678 F.3d 1357</div>
<div class='displayCitation'>bna a0d2d0n6c8</div>
<div class='displayCitation'>bna a0d2z8w7v7</div>
<div class='displayCitation'>bna a0d3g3h1v4</div>
<div class='displayCitation'>wkffecase:26085408</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1HO420003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="In re Baxter Int'l, Inc., 678 F.3d 1357, 102 U.S.P.Q.2d 1925 (Fed. Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="In re Baxter Int'l, Inc." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1HO420003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1HO420003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1HO420003" /><input id="title" name="title" type="hidden" value="In re Baxter Int'l, Inc., 678 F.3d 1357, 102 U.S.P.Q.2d 1925 (Fed. Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="f5e429a1cda65302a0d16c1e6b109ae0" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1HO420003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="true" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2Ff%35e%34%32%39a%31cda%36%35%33%30%32a%30d%31%36c%31e%36b%31%30%39ae%30%2Fdocument%2FX%31HO%34%32%30%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/bcite/X1HO420003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/bcite/X1HO420003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/bcite/X1HO420003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/related_content/X1HO420003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1709533298691";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,ReporterOfDecisions,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">678 F.3d 1357</div>
<div class="cite" data-cite-type="ReporterOfDecisions">102 U.S.P.Q.2d 1925</div>
<div class="cite" data-cite-type="DocketNumber">2011-1073</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 121025</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">U.S.P.Q.2d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">***</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Federal Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
In re BAXTER INTERNATIONAL, INC.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 2011-1073.
</center></p>
<p><center>
May 17, 2012.
<span CLASS="page_no" data-cite="102 uspq 2d 1927" data-cite-type="ReporterOfDecisions" data-cite-pageno="1927" data-primary-citation="102 U.S.P.Q.2d 1925">[**1927]</span> </center></p>
<span CLASS="page_no" data-cite="678 f 3d 1358" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1358" data-primary-citation="678 F.3d 1357">[*1358]</span> <div class="headnotesToggle clearfix"><button id="toggle_headnotes_button" class="bootstrap skinButton sourceButton wide right hideSource" data-target="#headnotes_container"><span>Hide Headnotes</span></button></div>
<div class="headnotesContainer" id="headnotes_container">
<div class="headnotesContainerTitle">BNA Headnotes</div>
<div class="headnoteTitle"><a href="http://www.bloomberglaw.com/document/1475619602000128">U.S. Patents Quarterly</a></div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_915868" href="#headnote_ref_pq2-dec_915868">[1]</a> <span>Practice and procedure in Patent and Trademark Office &mdash;
Board of Patent Appeals and Interferences &mdash; Rules and rules practice </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=110.1105" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="110.1105">&#9658;110.1105</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_1" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_1" class="headnoteContent"></div>
<div class="headnoteSlug">JUDICIAL PRACTICE AND PROCEDURE</div>
<div class="headnoteDescriptor">
<span>Procedure &mdash; Court of Appeals for the Federal Circuit </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.03" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.03">&#9658;410.03</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_2" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_2" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Procedure &mdash; Judicial review &mdash; Appealability </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.4603" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.4603">&#9658;410.4603</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_3" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_3" class="headnoteContent"></div>
<div class="headnote_text">
Patentee appealing from decision upholding rejection of claims during reexamination waived its arguments regarding means-plus-function limitation, since patentee recited relevant claim language in background of its opening brief before Board of Patent Appeals and Interferences, but it did not raise that limitation in &ldquo;arguments&rdquo; section of brief, since patentee did not address patent examiner's rejection of claim at issue in any respect in its reply brief, and board did not provide analysis of limitation, since order denying patentee's petition to remand reexamination to examiner did not preserve its arguments for appeal, and since patentee, therefore, failed to timely raise its arguments regarding limitation before board, and has not presented exceptional circumstance that would permit consideration of those arguments on appeal; however, patentee did timely raise its arguments regarding examiner's analysis of limitation in different claim, as well as substantive merit of those rejections, even though arguments did not specifically identify cases that patentee primarily relies upon on appeal.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_915869" href="#headnote_ref_pq2-dec_915869">[2]</a> <span>Patentability/Validity &mdash; Obviousness &mdash; Relevant prior art &mdash; Particular inventions </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=115.0903.03" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="115.0903.03">&#9658;115.0903.03</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_4" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_4" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Patent construction &mdash; Claims &mdash; Means </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=125.1307" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="125.1307">&#9658;125.1307</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_5" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_5" class="headnoteContent"></div>
<div class="headnote_text">
Substantial evidence supports finding by Board of Patent Appeals and Interferences that claim of patent directed to hemodialysis machine integrated with touch screen user interface is unpatentable for obviousness, since patent examiner and patentee agreed that structure corresponding to claim's &ldquo;means for controlling&rdquo;
limitation included microprocessor and concentrate pump, and examiner identified pump as corresponding structure for &ldquo;means for delivering the dialysate&rdquo; limitation, since descriptions in both prior art references cited by examiner are similar to microcontroller and concentrate pumps identified as corresponding structure to &ldquo;means for controlling&rdquo; limitation, since first reference discloses pumps that deliver dialysate to hemodialyzer as required by &ldquo;means for delivering the dialysate&rdquo; limitation, and pumps in that reference appear similar in structure and functionality to &ldquo;concentrate&rdquo;
pumps and pump lines identified as corresponding structure for limitation, and since second reference also teaches that pump delivers dialysate through flow meter into dialysate side of dialysis container used in connection with hemodialysis equipment.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_915870" href="#headnote_ref_pq2-dec_915870">[3]</a> <span>Practice and procedure in Patent and Trademark Office &mdash;
Re-examination &mdash; Requested by third party </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=110.1508" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="110.1508">&#9658;110.1508</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_6" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_6" class="headnoteContent"></div>
<div class="headnoteSlug">JUDICIAL PRACTICE AND PROCEDURE</div>
<div class="headnoteDescriptor">
<span>Procedure &mdash; Prior adjudication &mdash; In general </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.1501" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.1501">&#9658;410.1501</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_7" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_7" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Procedure &mdash; Burden of proof </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.35" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.35">&#9658;410.35</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_8" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_8" class="headnoteContent"></div>
<div class="headnote_text">
Board of Patent Appeals and Interferences, in upholding examiner's rejection of claim for obviousness in interpartes reexamination, did not improperly disregard federal appellate court decision finding that same patent challenger had failed to prove obviousness of claim at issue in civil litigation, since board expressly considered appellate court's decision, since patent challenger in civil litigation must prove invalidity by clear and convincing evidence, whereas standard of proof in reexamination proceedings is preponderance of evidence, and there is no presumption of patent validity, since appellate court found that patent challenger failed to identify structure in patent's specification, or in prior art, corresponding to means-plus-function limitations at issue, whereas patent examiner, during reexamination, sufficiently identified corresponding structures recited in patent and found in prior art, such that reasonable person might accept examiner's evidence to support finding that claim is not patentable under preponderance-of-evidence standard, and since examiner based rejection on prior art references that were not squarely at issue during civil trial of invalidity issues. </div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_915871" href="#headnote_ref_pq2-dec_915871">[4]</a> <span>Practice and procedure in Patent and Trademark Office &mdash;
Re-examination &mdash; Requested by third party </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=110.1508" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="110.1508">&#9658;110.1508</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_9" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_9" class="headnoteContent"></div>
<div class="headnoteSlug">JUDICIAL PRACTICE AND PROCEDURE</div>
<div class="headnoteDescriptor">
<span>Procedure &mdash; Prior adjudication &mdash; In general </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=410.1501" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="410.1501">&#9658;410.1501</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_10" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_10" class="headnoteContent"></div>
<div class="headnote_text">
When party who has lost in federal court proceeding challenging patent, from which no additional appeal is possible, provokes reexamination in U.S. Patent and Trademark Office using same presentations and arguments, PTO ideally should not arrive at a different conclusion, even though more lenient standard of proof applies in reexamination;
however, it is to be expected that any such reexamination would raise new issues, and in present case, in which patent examiner rejected claim for obviousness in interpartes reexamination after same patent challenger failed to prove obviousness of claim in civil litigation, PTO director apparently found that substantial new question of patentability had been raised, and examiner was then entitled to conduct reexamination on basis of new art presented and her own search of prior art, and controlling precedent precludes holding that PTO was barred from conducting reexamination of patent in suit because of final judgment in civil action.</div>
</div>
<div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="headnote">
<div class="headnoteSlug">PATENTS</div>
<div class="headnoteDescriptor">
<a name="headnote_pq2-dec_915872" href="#headnote_ref_pq2-dec_915872">[5]</a> <span>Patentability/Validity &mdash; Obviousness &mdash; Combining references </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=115.0905" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="115.0905">&#9658;115.0905</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_11" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_11" class="headnoteContent"></div>
<div class="headnoteDescriptor">
<span>Patent construction &mdash; Claims &mdash; Broad or narrow </span> <a href="http://www.bloomberglaw.com/document/1709533298691/class_outline_search?source_id=105.455998&amp;search_service_code=pq2co-ref&amp;search_node_id=125.1303" rel="ref" data-source-id="105.455998" data-service-code="pq2co-ref" data-node-id="125.1303">&#9658;125.1303</a> <span class="headnoteToggle">[<a href="#headnote_content_pq2coref_12" data-source-id="105.455998" class="toggle">Show Topic Path</a>]</span>
</div>
<div id="headnote_content_pq2coref_12" class="headnoteContent"></div>
<div class="headnote_text">
Board of Patent Appeals and Interferences, in upholding patent examiner's rejection of claims for obviousness in reexamination, did not improperly construe limitations at issue in claims directed to hemodialysis machine integrated with touch screen user interface, which recite touch screen that provides &ldquo;indicium soliciting&rdquo; specific information from machine's user, since board, by finding that limitation requires interface to prompt user for entry of specific data, properly applied construction of &ldquo;soliciting&rdquo;
that requires interface to actively seek action by user; under that construction, substantial evidence supports rejection of claims at issue, since one cited prior art reference depicts user interface that prompts user to input variety of time-varying parameters, and second reference discloses interface that prompts user to input pressure alarm limit, since third reference teaches delivery of anticoagulants to patient, and since substantial evidence supports finding that third reference, when combined with two references that disclose provision of &ldquo;indicium soliciting&rdquo; input from user, renders obvious limitation requiring &ldquo;indicium soliciting input from the user corresponding to a rate of anticoagulant delivery.&rdquo;</div>
</div>
</div>
<script type="text/javascript">
					jQuery(function($) {
						$('#toggle_headnotes_button').click(document_toggleHeadnoteVisibility);
					});
				</script><div id="para2" printdualcolumn="true"><p>
  William F. Lee, Wilmer Cutler Pickering Hale and Dorr, LLP,
of Boston, MA, argued for the appellant. With him on the brief
were William G. McElwain, David L. Cavanaugh, Todd C. Zubler,
Thomas G. Saunders and Heather M. Petruzzi, of Washington, DC.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Sydney O. Johnson, Jr., Associate Solicitor, Office of the
Solicitor, United States Patent and Trademark Office, of
Alexandria, VA, argued for appellee. With him on the brief were
Raymond T. Chen, Solicitor, and Janet A. Gongola, Associate
Solicitor. Of counsel was Scott C. Weidenfeller, Associate
Solicitor.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Michael E. Florey, Fish &amp; Richardson P.C., of Minneapolis,
MN, for amici curiae, Fresenius USA, Inc., et al.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Before NEWMAN, LOURIE, and MOORE, Circuit Judges.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Opinion for the court filed by Circuit Judge LOURIE. Dissenting
opinion filed by Circuit Judge NEWMAN.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  LOURIE, Circuit Judge.
</p></div>
<div id="contentOpinion" printdualcolumn="true">
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Baxter International Inc. ("Baxter") appeals from the
decision of the Board of Patent Appeals and Interferences ("the
Board") affirming the examiner's rejections of claims <span CLASS="page_no" data-cite="102 uspq 2d 1928" data-cite-type="ReporterOfDecisions" data-cite-pageno="1928" data-primary-citation="102 U.S.P.Q.2d 1925">[**1928]</span> 26-31 of
U.S. Patent 5,247,-434 ("the &prime;434 patent") for
obviousness under <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XEIVVE003?jcsearch=35%20U.S.C.%20%20103(a)&amp;summary=yes#jcite">35 U.S.C. &sect; 103</a>(a). <i>See Ex parte</i>
<i>Baxter Int'l Inc.</i>, No. 2009-006493, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980
(B.P.A.I. Mar. 18, 2010) ("<i>Board Decision"); Ex parte</i>
<i>Baxter Int'l Inc.</i>, No. <cite>2009-006493</cite>, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X878NRG5GVG0?jcsearch=Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 3032865
(B.P.A.I. July 20, 2010) ("<i>Board Rehearing Decision</i>").
Because the Board did not err in determining that those claims
would have been obvious to one of ordinary skill in the art, we
<i>affirm.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               BACKGROUND
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   I.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This patent appeal relates to hemodialysis machines that can
function in place of a patient's kidney to cleanse the blood of
toxins using a solution called a dialysate. During
hemodialysis, the patient's blood is pumped though the
hemodialysis machine and the dialysate acts to absorb the
toxins. To ensure that the process does not filter essential
nutrients from the blood, a hemodialysis machine must
facilitate the monitoring and control of a number of
parameters.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Baxter owns the &prime;434 patent, entitled "Method and
Apparatus for Kidney Dialysis," which discloses and claims a
hemodialysis machine integrated with a touch screen user
interface that allows an operator to monitor and control a
number of parameters. Figure 8 of the patent, reproduced below,
depicts an exemplary touch screen interface:
<span CLASS="page_no" data-cite="678 f 3d 1359" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1359" data-primary-citation="678 F.3d 1357">[*1359]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1HO420003?documentName=68395_n">Exhibit</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As depicted above, the interface allows an operator to monitor
and control a number of treatment parameters, such as the
dialysate temperature, and the patent details the computer
system that interfaces with the touch screen to control the
delivery of the dialysate <span CLASS="page_no" data-cite="102 uspq 2d 1929" data-cite-type="ReporterOfDecisions" data-cite-pageno="1929" data-primary-citation="102 U.S.P.Q.2d 1925">[**1929]</span> and other liquids. Claim 26 of the
patent, reproduced below, recites the elements of the
integrated hemodialysis machine:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  26. A hemodialysis machine comprising:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  (a) <i>means for controlling a dialysate</i>
  <i>parameter</i> selected from a group consisting of
  dialysate temperature and dialysate concentration, and
  <i>means for delivering the dialysate to a dialysate</i>
  <i>compartment of a hemodialyzer</i>; and
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  (b) a user/machine interface operably coupled to said
  dialysate-delivery means, the user/machine interface
  comprising a <span CLASS="page_no" data-cite="2012 bl 121025 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[***2]</span> touch screen adapted to display an
  indicium corresponding to a parameter pertinent to
  operation of the hemodialysis machine for performing
  hemodialysis and to permit the user, by touching the
  indicium, to cause a change in the parameter.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
434 patent, col.40 ll.29-43 (emphases added). Dependent claim
30 includes an additional means plus function limitation,
reciting that the hemodialysis machine further comprises a
"means for delivering an anticoagulant to a patient."
<i>Id.</i> col.40 ll.60-64. Finally, dependent claims 27, 30,
and 31 recite that the touch screen provide "indicium
soliciting" specific information from the machine's user:
"programmed settings of a time-varying machine-operating
parameter" (claim 27); "input from the user corresponding to a
rate of anticoagulant delivery" (claim 30); or "a programmed
setting of an alarm limit about the machine-operating
parameter" (claim 31). <i>Id.</i> col.40 ll.44-47, 60-68.
<span CLASS="page_no" data-cite="678 f 3d 1360" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1360" data-primary-citation="678 F.3d 1357">[*1360]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   II.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The &prime;434 patent has been subject to litigation. In 2003,
one of Baxter's competitors, Fresenius, filed a declaratory
judgment action in the United States District Court for the
Northern District of California, seeking, among other claims, a
declaration that the patent's claims were invalid.
<i>Fresenius Med. Care Holdings, Inc. v. Baxter Int'l,</i>
<i>Inc.</i>, No. C 03-1431 SBA, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X169OPI003?jcsearch=2007%20BL%20224451&amp;summary=yes#jcite">2007 BL 224451</a>], 2007 WL 518804, at *1
(N.D.Cal. Feb. 13, 2007). The parties tried Fresenius's invalidity claims
to a jury, which found that Fresenius had proved by clear and
convincing evidence that claims 26-31 of the patent would have
been obvious at the time the invention was made. <i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X169OPI003?jcsearch=2007%20BL%20224451&amp;summary=yes#jcite">Id.
at *2</a>. After trial, Baxter moved for judgment as a matter of
law, and the district court granted Baxter's motion.
<i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X169OPI003?jcsearch=2007%20BL%20224451&amp;summary=yes#jcite">Id. at *2</a>, *8-9. In particular,- the district court
concluded that Fresenius failed as a matter of law to show by
clear and convincing evidence that Fresenius's proffered prior
art, <b><i>viz.</i></b>, the CMS 08 Manual, the Cobe C3 Manual, or
the Seratron System, contained the "means for controlling" and
"means for delivering" limitations of claim 26. <i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X169OPI003?jcsearch=2007%20BL%20224451&amp;summary=yes#jcite">Id. at
*8</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Upon the entry of a final judgment, Fresenius appealed. We
affirmed the district court's grant of judgment as a matter of
law, but for "somewhat different reasons than those articulated
by the district court." <i>Fresenius USA, Inc. v. Baxter</i>
<i>Int'l, Inc.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20f%203d%201288&amp;summary=yes#jcite">582 F.3d 1288</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20f%203d%201288&amp;summary=yes#jcite">1299</a> (Fed. Cir. 2009). We
concluded that "Fresenius failed to present any evidence
&mdash; let alone substant[ia] evidence &mdash; that the
structure corresponding to the means for delivering dialysate
limitation [in claim 26], or an equivalent thereof, existed in
the prior art." <i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20F.3d%201288&amp;summary=yes#jcite">Id.</a></i> In particular, Fresenius failed to
identify "the structure in the specification that corresponds
to the means for delivering dialysate" and further failed to
compare the identified structure to those structures present in
the prior art. <i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20F.3d%201288&amp;summary=yes#jcite">Id. at 1300</a>. We thus held that the
district court correctly granted Baxter's motion for judgment
as a matter of law. <i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20F.3d%201288&amp;summary=yes#jcite">Id.</a></i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                  III.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2006, in parallel with the <i>Fresenius</i> litigation,
the United States Patent &amp; Trademark Office ("PTO") began
to reexamine the &prime;434 patent, stimulated by Fresenius. In
the course of those proceedings, the examiner found that a
number of references rendered obvious claims 26-31 of the
patent, including, <span CLASS="page_no" data-cite="2012 bl 121025 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[***3]</span> among other references, the CMS 08 Manual,
the Sarns 9000 Manual, U.S. Patent 4,370,983 ("Lichtenstein"),
and U.S. Patent 4,710,166 ("Thompson"). Specifically, with
regard to claims 26-29 and 31, the examiner concluded that
those claims would have been obvious in light of the combined
teachings of the CMS 08 Manual, Lichtenstein, the Sarns 9000
Manual, and two other references not at issue on appeal.
<i>Board Decision</i>, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980, at *4. Regarding
claim 30, the examiner concluded that it would not have been
patentable over a combination of the same references in view of
Thompson. <i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20F.3d%201288&amp;summary=yes#jcite">Id</a>.<span CLASS="page_no" data-cite="102 uspq 2d 1930" data-cite-type="ReporterOfDecisions" data-cite-pageno="1930" data-primary-citation="102 U.S.P.Q.2d 1925">[**1930]</span> </i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Baxter appealed the examiner's final rejections to the Board.
After briefing and oral argument before the Board but prior to
issuance of the Board's decision, we decided the
<i>Fresenius</i> case. Shortly thereafter, Baxter petitioned
the Director of the PTO to remand the reexamination to the
examiner to consider the rejections in light of our
<i>Fresenius</i> decision. The Director denied the petition
but ordered the Board to consider our decision in
<i>Fresenius.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Board affirmed the examiner's rejections of claims 26-31.
Regarding our <i>Fresenius</i> decision, the Board discussed
the holding of the case and concluded that "[a]lthough claims
26-31 were not proven
<span CLASS="page_no" data-cite="678 f 3d 1361" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1361" data-primary-citation="678 F.3d 1357">[*1361]</span> 
invalid in court, a lower standard of proof and the
broadest reasonable interpretation standard of claim
construction apply at the PTO and therefore the agency is not
bound by the court's determination." <i>Board Decision</i>,
[<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980, at *12 (citing <i>Ethicon, Inc. v.</i>
<i>Quigg</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XAFJFV?jcsearch=849%20f%202d%201422&amp;summary=yes#jcite">849 F.2d 1422</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XAFJFV?jcsearch=849%20f%202d%201422&amp;summary=yes#jcite">1429</a> (Fed. Cir. 1988); <i>In re</i>
<i>Swanson</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19GM74003?jcsearch=540%20f%203d%201368&amp;summary=yes#jcite">540 F.3d 1368</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19GM74003?jcsearch=540%20f%203d%201368&amp;summary=yes#jcite">1377</a> (Fed. Cir. 2008)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Turning to the merits of the examiner's rejections, the Board
found that the CMS 08 Manual describes the "control of Na, K,
and HC03 flow rates using a control unit that may be programmed
in ten minute intervals (i.e., a microprocessor) and a pump
driven by a stepper motor," a disclosure that met the
corresponding structure in the specification identified by
Baxter and the examiner for the "means for controlling"
limitation. <i>Board Decision</i>, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980, at *14.
The Board also found that Baxter "did not assert that
Lichtenstein lacks any structure corresponding to element (a)
of claim 26" and thus declined to address the rejections based
on Lichtenstein. <i>Id.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Board also affirmed the examiner's findings regarding the
"soliciting" limitations in claims 27, 30, and 31. With respect
to claim 27, the Board found that the CMS 08 Manual disclosed
that a user can adjust or control time-dependent hemodialysis
parameters such as the ultrafiltrate rate and the concentration
of substances in the dialysate. <i>Board Decision</i>,
[<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980, at *14. Regarding claim 30, the Board found that
Thompson in combination with the CMS 08 Manual or the Sarns
9000 Manual rendered obvious the "indicium soliciting input
from the user corresponding to a rate of anticoagulant
delivery" limitation. <i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">Id</a>.</i> at *9-10, *15. Finally, the
Board found that the Sarns 9000 Manual described the "indicium
soliciting, from the user, a programmed setting of an alarm
limit about the machine-operating parameter" limitation in
claim 31. <i>Id.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Following the Board decision, Baxter requested rehearing, which
the Board denied. <i>Board Rehearing Decision</i>,
[<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X878NRG5GVG0?jcsearch=Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 3032865, <span CLASS="page_no" data-cite="2012 bl 121025 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[***4]</span> at *1. In particular, the Board rejected Baxter's
argument that the Board had erroneously equated "soliciting"
with "control" or "adjust," reiterating that the CMS 08 Manual
disclosed that "the machine interface solicits the user for
entry of data to control various parameters such as sodium
concentration." <i>Id.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Baxter timely appealed, and we have jurisdiction under
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XEIMUG003?jcsearch=28%20U.S.C.%20%201295(a)(4)(A)&amp;summary=yes#jcite">28 U.S.C. &sect; 1295</a>(a)(4)(A).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               DISCUSSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   I.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The scope of our review in an appeal from a Board decision is
limited. We review the Board's factual findings for substantial
evidence and review the Board's legal conclusions <i>de novo.</i>
<i>In re Kotzab</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X3FFT6?jcsearch=217%20f%203d%201365&amp;summary=yes#jcite">217 F.3d 1365</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X3FFT6?jcsearch=217%20f%203d%201365&amp;summary=yes#jcite">1369</a> (Fed. Cir. 2000). A
finding is supported by substantial evidence if a reasonable
mind might accept the evidence to support the finding.
<i>Consol. Edison Co. v. NLRB</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BVRN?jcsearch=305%20us%20197&amp;summary=yes#jcite">305 U.S. 197</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BVRN?jcsearch=305%20us%20197&amp;summary=yes#jcite">229</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BVRN?jcsearch=59%20supreme%20court%20206&amp;summary=yes#jcite">59 S.Ct. 206</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BVRN?jcsearch=83%20l%20ed%20126&amp;summary=yes#jcite">83 L.Ed. 126</a> (1938).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although the ultimate determination of obviousness under
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XEIVVE003?jcsearch=35%20usc%20103&amp;summary=yes#jcite">35 U.S.C. &sect; 103</a> is a question of law, it is based on several
underlying factual findings, including the differences between
the claimed invention and the prior art. <i>Graham v. John</i>
<i>Deere Co.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C6EI?jcsearch=383%20us%201&amp;summary=yes#jcite">383 U.S. 1</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C6EI?jcsearch=383%20us%201&amp;summary=yes#jcite">17-18</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C6EI?jcsearch=86%20supreme%20court%20684&amp;summary=yes#jcite">86 S.Ct. 684</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C6EI?jcsearch=15%20l%20ed%202d%20545&amp;summary=yes#jcite">15 L.Ed.2d 545</a>
(1966). Similarly, the determination of what a reference
teaches is a question of fact. <i>Rapoport v. Dement</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X50U3G?jcsearch=254%20f%203d%201053&amp;summary=yes#jcite">254 F.3d 1053</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X50U3G?jcsearch=254%20f%203d%201053&amp;summary=yes#jcite">1060-61</a> (Fed. Cir. 2001); <i>see also In re</i>
<i>Gartside</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X3F7BT?jcsearch=203%20f%203d%201305&amp;summary=yes#jcite">203 F.3d 1305</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X3F7BT?jcsearch=203%20f%203d%201305&amp;summary=yes#jcite">1316</a> (Fed. Cir. 2000). Thus, we
review those factual determinations for substantial evidence.
<i>Kotzab</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X3FFT6?jcsearch=217%20f%203d%201365&amp;summary=yes#jcite">217 F.3d at 1369</a>.
<span CLASS="page_no" data-cite="678 f 3d 1362" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1362" data-primary-citation="678 F.3d 1357">[*1362]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In contrast, claim construction is a legal issue that we review
<i>de novo. Cybor Corp. v. FAS Techs., Inc.</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X4Q5NA?jcsearch=138%20f%203d%201448&amp;summary=yes#jcite">138 F.3d 1448</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X4Q5NA?jcsearch=138%20f%203d%201448&amp;summary=yes#jcite">1454-55</a> (Fed. Cir. 1998) (en banc). To ascertain the scope
and meaning of the asserted claims, we look to the words of the
claims themselves, the specification, the prosecution <span CLASS="page_no" data-cite="102 uspq 2d 1931" data-cite-type="ReporterOfDecisions" data-cite-pageno="1931" data-primary-citation="102 U.S.P.Q.2d 1925">[**1931]</span> history,
and, lastly, any relevant extrinsic evidence. <i>Phillips v.</i>
<i>AWH Corp.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X12HHT2003?jcsearch=415%20f%203d%201303&amp;summary=yes#jcite">415 F.3d 1303</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X12HHT2003?jcsearch=415%20f%203d%201303&amp;summary=yes#jcite">1315-17</a> (Fed. Cir. 2005) (en
banc).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   II.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   A.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As an initial matter, the PTO argues that Baxter waived its
arguments regarding the "means plus function" limitations in
claims 26 and 30 because it failed to timely present those
arguments to the Board. Baxter responds that it presented those
issues to the Board in its opening brief, its reply brief, and
at oral argument. Baxter also argues that the Director allowed
Baxter to pursue those arguments in its order denying Baxter's
petition to remand the case from the Board to the examiner.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_915868" href="#headnote_pq2-dec_915868">[1]</a> We agree with the PTO that Baxter waived its arguments
regarding the "means for delivering an anticoagulant"
limitation in claim 30 by failing to timely raise them before
the Board. Absent exceptional circumstances, <i>see In re</i>
<i>DBC</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19SB52003?jcsearch=545%20f%203d%201373&amp;summary=yes#jcite">545 F.3d 1373</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19SB52003?jcsearch=545%20f%203d%201373&amp;summary=yes#jcite">1379-80</a> (Fed. Cir. 2008), we generally
do not consider arguments that the applicant failed to present
to the Board, <i>In re Watts</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X6B77V?jcsearch=354%20f%203d%201362&amp;summary=yes#jcite">354 F.3d 1362</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X6B77V?jcsearch=354%20f%203d%201362&amp;summary=yes#jcite">1367-68</a>
(Fed. Cir. 2004). Although Baxter recited the "means for
delivering anticoagulant" claim language in the background of
its opening brief before the Board, Baxter did not raise that
limitation in the arguments section, instead arguing that
"Claim 30 Is Patentable Because the Prior Art, Including the
Thompson Patent, Fails To Teach or Suggest Touch-Screen
Control." J.A. 7883:11a, 7883:59a. In its reply brief before
the Board, Baxter did not address the examiner's rejection of
claim 30 in any respect. <i>See</i> J.A. 9358-59.
Unsurprisingly, the Board did not provide an analysis of the
"means for delivering an anticoagulant limitation," but only
addressed Baxter's arguments regarding <span CLASS="page_no" data-cite="2012 bl 121025 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[***5]</span> the "indicium soliciting
from the user" limitation of claim 30. <i>Board Decision</i>,
[<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980, at *9-10, *15.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Ultimately, Baxter failed to raise the "means for delivering an
anticoagulant" limitation before the Board, and, contrary to
Baxter's arguments, the Director's order denying Baxter's
petition did not preserve for appeal arguments relating to a
claim limitation that Baxter never put at issue before the
Board. Finally, Baxter has not presented an exceptional
circumstance that would allow us to consider arguments that it
failed to present to the Board. We accordingly decline to
address them.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The record does indicate, however, that Baxter timely raised
its arguments regarding the examiner's analysis of limitation
(a) of claim 26 as well as the substantive merit of those
rejections, at least regarding the rejections based on the CMS
08 Manual. J.A. 7883:42a-45a. While those arguments did not
specifically name the cases that Baxter primarily relies upon
on appeal, we do not require such case specificity to preserve
a point of error for appeal. <i>See Nelson v. Adams USA</i>
<i>Inc.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2TTTB?jcsearch=529%20us%20460&amp;summary=yes#jcite">529 U.S. 460</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2TTTB?jcsearch=529%20us%20460&amp;summary=yes#jcite">469-70</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2TTTB?jcsearch=120%20supreme%20court%201579&amp;summary=yes#jcite">120 S.Ct. 1579</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2TTTB?jcsearch=146%20l%20ed%202d%20530&amp;summary=yes#jcite">146 L.Ed.2d 530</a> (2000) (explaining that the general rule of error
preservation "does not demand the incantation of particular
words" but simply requires that the lower tribunal "be fairly
put on notice as to the substance of the issue"). Thus, we will
address Baxter's arguments on those issues.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   B.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Regarding claim 26, Baxter raises a number of arguments on
appeal. First,
<span CLASS="page_no" data-cite="678 f 3d 1363" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1363" data-primary-citation="678 F.3d 1357">[*1363]</span> 
Baxter argues that the PTO failed to perform the structural
analysis required by <i>In re Donaldson Co.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X4KLJ8?jcsearch=16%20f%203d%201189&amp;summary=yes#jcite">16 F.3d 1189</a>
(Fed. Cir. 1994). Baxter also argues that the Board's findings
that the prior art discloses the "means for controlling" and
"means for delivering the dialysate" limitations are not
supported by substantial evidence and contradict the findings
of the district court and this court in the <i>Fresenius</i>
litigation, to both of which the PTO failed to give serious
consideration. Regarding the "means for controlling"
limitation, Baxter argues that none of the pages of the prior
art references cited by the examiner and the Board actually
disclose a microprocessor. With respect to the "means for
delivering" limitation, Baxter argues that the prior art "pumps
and pump lines" identified by the examiner do not deliver
dialysate to a dialysate compartment of a hemodialyzer but
instead deliver fluids to other destinations.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The PTO responds that a structural analysis was performed for
the "means for controlling" and "means for delivering"
limitations. It also argues that substantial evidence shows
that the CMS 08 Manual and Lichtenstein disclose the structure
corresponding to the challenged means plus function
limitations. Finally, the PTO argues that the lower court's
decision and this court's decision in <i>Fresenius<span CLASS="page_no" data-cite="102 uspq 2d 1932" data-cite-type="ReporterOfDecisions" data-cite-pageno="1932" data-primary-citation="102 U.S.P.Q.2d 1925">[**1932]</span> </i> do not
control the reexamination proceeding because the PTO and the
court system apply different approaches to determine invalidity
and patentability.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_915869" href="#headnote_pq2-dec_915869">[2]</a> We agree with the PTO that substantial evidence supported the
Board's findings on claim 26. Regarding Baxter's arguments that
the examiner did not specifically determine <span CLASS="page_no" data-cite="2012 bl 121025 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[***6]</span> the corresponding
structure for the "means plus function" limitations in
limitation (a), the record indicates that both the examiner and
Baxter agreed that the corresponding structure disclosed in the
specification for the "means for controlling" limitation
included a microprocessor and a concentrate pump. <i>Board</i>
<i>Decision</i>, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980, at *14; J.A. 9283-84.
Similarly, rather than engage in a purely functional analysis
of the "means for delivering the dialysate" limitation, the
examiner identified a pump, the same type of structure that
Baxter contends is the corresponding structure for the "means
for delivering the dialysate" limitation. <i>See</i> J.A.
7883:10a, 9284.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Turning to Baxter's specific arguments regarding the teachings
disclosed in the references, we conclude that substantial
evidence supports the Board's finding that the prior
art discloses limitation (a) of claim 26. Regarding the "means for
controlling" limitation, the CMS 08 Manual discloses a
"computer modeling system" with a "[p]rocessor" and describes
that "electrolyte concentrations" are delivered via "stepper
motor driven line pumps" that can be "programmed in ten minute
intervals." J.A. 284, 288, 290. Even if Baxter could overcome
the Board's express finding that Baxter "did not assert that
Lichtenstein lacks any structure corresponding" to limitation
(a) of claim 26, <i>Board Decision</i>, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X7NNORG5GVG0?jcsearch=%20Appeal%202009-6493&amp;summary=yes#jcite">APPEAL 2009-6493</a>], 2010 WL 1048980, at
*14, that reference, in any event, discloses a "microcomputer"
that is programmable to carry out specific procedures,
including hemodialysis. Lichtenstein, col.3 ll.64-65, col.8
11.23-25; <i>see also id.</i> col.20 ll.9-15 ("Computer
systems such as the . . . Intel `Multibus' for its SBC 80
Microcomputer System, can be purchased as assembled units to
provide the microcomputer functions, when appropriately
programmed."). The descriptions in both references are similar
to the microcontroller and concentrate pumps identified by
Baxter as the corresponding structure for the "means for
controlling" limitation. &prime;434 patent, col.16 ll.45-48,
col.17 ll.29-33 (explaining that the microprocessor is "built
using an Intel 8040 microcontroller" and that the concentrate
<span CLASS="page_no" data-cite="678 f 3d 1364" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1364" data-primary-citation="678 F.3d 1357">[*1364]</span> 
pumps "are stepper motor driven . . . diaphragm pumps which
deliver a calibrated volume of concentrate per stepper motor
revolution").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Substantial evidence also supports the Board's finding that the
prior art disclosed structure corresponding to the "means for
delivering the dialysate" limitation. While Baxter argues that
the specific pumps in the CMS 08 Manual do not deliver
dialysate to a dialysate compartment of a hemodialyzer but
instead perform other functions, the reference discloses a
"dialysate mixing system" that must be connected to a
hemodialyzer, which necessarily requires the dialysate to be
pumped between the machines. J.A. 292-99. In addition, on their
face, the pumps identified by the examiner in the CMS 08 Manual
appear similar in structure and functionality to the
"concentrate" pumps and pump lines that Baxter identified as
corresponding structure in the &prime;434 patent for this
"means plus function" limitation. J.A. 7883:10a (identifying
concentrate <span CLASS="page_no" data-cite="2012 bl 121025 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[***7]</span> pump 22 and "the associated structure"). Further,
even if Baxter's arguments regarding Lichtenstein are properly
before us, that reference also teaches that a pump delivers
dialysate through a flow meter into the dialysate side of a
dialysis container used in connection with hemodialysis
equipment. Lichtenstein, col.12 ll.60-61, col.13 ll.41-17.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_915870" href="#headnote_pq2-dec_915870">[3]</a> We also reject Baxter's argument that the Board erred because
it "ignored" our decision in <i>Fresenius</i> and failed to
"give serious consideration" to the district court's
<i>Fresenius</i> decision. Opening Br., Baxter Int'l Inc.
at 36, 41, <cite>2011 WL 5997217</cite>. First, as recounted above, the Board
expressly considered our decision in <i>Fresenius.</i> More
fundamentally, the PTO in reexamination proceedings and the
court system in patent infringement actions "take different
approaches in determining validity and on the same evidence
could quite correctly come to different conclusions."
<i>Swanson</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19GM74003?jcsearch=540%20f%203d%201368&amp;summary=yes#jcite">540 F.3d at 1377</a> (quoting <i>Ethicon</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XAFJFV?jcsearch=849%20f%202d%201422&amp;summary=yes#jcite">849 F.2d at 1428</a>). In particular, a challenger that attacks the
validity of patent claims in civil litigation has a statutory
burden to prove invalidity by clear and convincing evidence.
<i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19GM74003?jcsearch=540%20F.3d%201368&amp;summary=yes#jcite">Id</a>.</i> (citing <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XEJ050003?jcsearch=35%20usc%20282&amp;summary=yes#jcite">35 U.S.C. &sect; 282</a>); <i>see also</i>
<i>Microsoft Corp. v. 14i Ltd.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1FI916003?jcsearch=131%20S.Ct.%202238&amp;summary=yes#jcite">___ U.S. ___</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1FI916003?jcsearch=131%20supreme%20court%202238&amp;summary=yes#jcite">131 S.Ct. 2238</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1FI916003?jcsearch=131%20supreme%20court%202238&amp;summary=yes#jcite">2242</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1FI916003?jcsearch=180%20l%20ed%202d%20131&amp;summary=yes#jcite">180 L.Ed.2d 131</a> (2011). Should the challenger fail to
meet that burden, the court will <span CLASS="page_no" data-cite="102 uspq 2d 1933" data-cite-type="ReporterOfDecisions" data-cite-pageno="1933" data-primary-citation="102 U.S.P.Q.2d 1925">[**1933]</span> not find the patent "valid,"
only that "the patent challenger did not carry the `burden of
establishing invalidity in the <i>particular case</i> before
the court.'" <i>Swanson</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19GM74003?jcsearch=540%20f%203d%201368&amp;summary=yes#jcite">540 F.3d at 1377</a> (quoting
<i>Ethicon</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XAFJFV?jcsearch=849%20f%202d%201422&amp;summary=yes#jcite">849 F.2d at 1429</a> n. 3 (internal citations
omitted)). In contrast, in PTO reexaminations "the standard of
proof &mdash; a preponderance of the evidence &mdash; is
substantially lower than in a civil case" and there is no
presumption of validity in reexamination proceedings.
<i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X19GM74003?jcsearch=540%20F.3d%201368&amp;summary=yes#jcite">Id. at 1378</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This case thus illustrates the distinction between a
reexamination and a district court proceeding. In
<i>Fresenius</i>, we up-held the district court's grant of
judgment as a matter of law because the patent challenger
failed to meet its burden to prove invalidity by clear and
convincing evidence &mdash; it "failed to present any evidence
. . . that the structure corresponding to the means for
delivering dialysate limitation [in claim 26], or an equivalent
thereof, existed in the prior art" and did not identify "the
structure in the specification that corresponds to the means
for delivering dialysate" or compare the identified structure
to those structures present in the prior
art. <i>Fresenius</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20f%203d%201288&amp;summary=yes#jcite">582 F.3d at 1299</a>. Ultimately, we concluded
that the clear and convincing burden of proof in the "means
plus function" context "cannot be carried without clearly
identifying the corresponding structure in the prior art."
<i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1BN34Q003?jcsearch=582%20F.3d%201288&amp;summary=yes#jcite">Id. at 1300</a>.
<span CLASS="page_no" data-cite="678 f 3d 1365" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1365" data-primary-citation="678 F.3d 1357">[*1365]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In contrast, during the reexamination, the examiner
sufficiently identified the corresponding structure recited in
the &prime;434 patent and identified the structures in the
prior art such that a reasonable person might accept that
evidence to support a finding that claim 26 is not patentable
under a preponderance of the evidence standard of proof.
Moreover, in addition to relying on the CMS 08 Manual, the
examiner based those rejections on prior art references that
were not squarely at issue during the trial on the invalidity
issues, such <span CLASS="page_no" data-cite="2012 bl 121025 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[***8]</span> as Lichtenstein and Thompson. <i>See</i>
<i>Fresenius</i>, [<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X169OPI003?jcsearch=2007%20BL%20224451&amp;summary=yes#jcite">2007 BL 224451</a>], 2007 WL 518804, at *7-8 (discussing the Cobe C3
Manual, the CMS 08 Manual, the Sarns 9000, and the Seratron
System). Thus, because the two proceedings necessarily applied
different burdens of proof and relied on different records, the
PTO did not err in failing to provide the detailed explanation
now sought by Baxter as to why the PTO came to a different
determination than the court system in the <i>Fresenius</i>
litigation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_915871" href="#headnote_pq2-dec_915871">[4]</a> Lest it be feared that we are erroneously elevating a decision
by the PTO over a decision by a federal district court, which
decision has been affirmed by this court, the following
additional comments must be made. When a party who has lost in
a court proceeding challenging a patent, from which no
additional appeal is possible, provokes a reexamination in the
PTO, using the same presentations and arguments, even with a
more lenient standard of proof, the PTO ideally should not
arrive at a different conclusion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  However, the fact is that Congress has provided for a
reexamination system that permits challenges to patents by
third parties, even those who have lost in prior judicial
proceedings. Usually one would expect that any such
reexamination, such as the one before us, would raise new
issues. In this case, the patent examiner relied on new prior
art that had not been raised in the prior district court
proceeding. Why Fresenius did not present that prior art before
the district court we do not know. But the Director apparently
found that a substantial new question of patentability had been
raised and the examiner was then entitled to conduct a
reexamination on the basis of the new art presented and her
search of the prior art. Thus, this case is not about the
relative primacy of the courts and the PTO, about which there
can be no dispute. Finally, we could not conclude that the PTO
was barred from conducting the reexamination of the &prime;434
patent because of the final judgment in <i>Fresenius</i>
without overruling <i>Ethicon</i> and <i>Swanson</i>, which
we cannot do. <i>See Hometown Fin., Inc. v. United</i>
<i>States</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X12BMP8003?jcsearch=409%20f%203d%201360&amp;summary=yes#jcite">409 F.3d 1360</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X12BMP8003?jcsearch=409%20f%203d%201360&amp;summary=yes#jcite">1365</a> (Fed. Cir. 2005) ("[W]e are
bound to follow our own precedent as set forth by prior panels
").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                                   C.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Lastly, Baxter argues that the Board erroneously construed the
term "soliciting" in claims 27, 30, and 31 and, under a correct
construction of that term, the rejections of those claims were
not supported by substantial evidence. In particular, Baxter
argues that the Board implicitly construed "soliciting" in an
over-broad manner to encompass a touch screen user interface
that allows a user to adjust or control the machine, a
construction that is not supported by the specification. Baxter
argues that the term should have been construed to require the
machine to actively seek an action by a user.
<span CLASS="page_no" data-cite="102 uspq 2d 1934" data-cite-type="ReporterOfDecisions" data-cite-pageno="1934" data-primary-citation="102 U.S.P.Q.2d 1925">[**1934]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a id="headnote_ref_pq2-dec_915872" href="#headnote_pq2-dec_915872">[5]</a> We disagree. The PTO does not dispute Baxter's construction of
"soliciting" as requiring the touch screen user interface to
actively seek an action by the user, and the Board applied a
construction identical in scope, requiring the machine
interface to prompt the user for entry of specific data. J.A.
40. That requirement finds support
<span CLASS="page_no" data-cite="2012 bl 121025 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[***9]</span> <span CLASS="page_no" data-cite="678 f 3d 1366" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1366" data-primary-citation="678 F.3d 1357">[*1366]</span> 
in the written description. <i>E.g.</i>, &prime;<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2GGGE41H0J?jcsearch=usp%205247434&amp;summary=yes#jcite">434
patent</a>, col.10 ll.1-6 (describing that the machine "solicits" a
sodium value "by means of a pop-up keypad").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under that construction, substantial evidence supports the
rejections of claims 27, 30, and 31. In particular, the CMS 08
Manual discloses the "soliciting" limitation in claim 27
because the reference depicts a user interface that prompts the
user to input a variety of time-varying operating parameters,
such as the ultrafiltration rate and the sodium electrolyte
profile. J.A. 307-08. Similarly, substantial evidence supports
the PTO's finding that the Sarns 9000 Manual teaches the
"soliciting" limitation in claim 31 because that reference
discloses a user interface that prompts the user to input a
pressure alarm limit. J.A. 450.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finally, substantial evidence supports the Board's finding that
the CMS 08 Manual or the Sarns 9000 Manual, when combined with
Thompson, renders obvious the "indicium soliciting input from
the user corresponding to a rate of anticoagulant delivery"
limitation in claim 30. As explained above, the CMS 08 Manual
and the Sarns 9000 Manual disclose providing an "indicium
soliciting" input from a user. Baxter does not contest that
Thompson teaches delivering anticoagulants to a patient. See
Thompson, coll 11.9-25. Nor does Baxter contest on appeal that,
in view of Thompson's disclosure, it would have been obvious to
one of ordinary skill in the art to modify the user interface
described in the CMS 08 Manual or the Sarns 9000 Manual to
provide an indicium soliciting input from the user that
corresponds to a rate of anticoagulant delivery.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                               CONCLUSION
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have considered Baxter's remaining arguments and conclude
that they are without merit. For the foregoing reasons, the
Board's determination that claims 26-31 were not patentable is
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>AFFIRMED</b>
</p></div>
</div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  NEWMAN, Circuit Judge, dissenting.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Patent and Trademark Office's Board of Patent Appeals
and Interferences, on reexamination of a patent that had
previously been litigated to final judgment in the district
court and on appeal to the Federal Circuit, states that "the
agency is not bound by the court's determination." BPAI Op.
at 26. My colleagues appear unperturbed by the agency's
nullification of this court's final decision. Instead, the
court itself ignores our own prior final decision, although it
is the law of this case. Thus the court violates not only the
constitutional plan, but also violates the rules of litigation
repose as well as the rules of estoppel and preclusion &mdash;
for the issue of validity, the evidence, and the parties in
interest are the same in this agency reexamination as in the
finally resolved litigation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  No authority, no theory, no law or history, permits
administrative nullification of a final judicial decision.
No concept of government authorizes an administrative agency to
override or disregard the final judgment of a court. Judicial
rulings are not advisory; they are obligatory. In <i>San Remo</i>
<i>Hotel, L.P. v. City &amp; County of San Francisco</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XRI2E7QNB5G0?jcsearch=545%20U.S.%20323&amp;summary=yes#jcite">545 U.S. 323</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XRI2E7QNB5G0?jcsearch=125%20supreme%20court%202491&amp;summary=yes#jcite">125 S.Ct. 2491</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XRI2E7QNB5G0?jcsearch=162%20l%20ed%202d%20315&amp;summary=yes#jcite">162 L.Ed.2d 315</a> (2005) the Court
explained:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The general rule implemented by the full faith and
  credit <span CLASS="page_no" data-cite="2012 bl 121025 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[***10]</span> statute &mdash; that parties should not be
  permitted to relitigate issues that have been resolved
  by courts of competent jurisdiction &mdash; predates
  the Republic. It "has found its way into every system
  of jurisprudence, not only from its obvious fitness
  and propriety, but because without it, an end could
  never be put to litigation."
<span CLASS="page_no" data-cite="678 f 3d 1367" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1367" data-primary-citation="678 F.3d 1357">[*1367]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XRI2E7QNB5G0?jcsearch=545%20U.S.%20323&amp;summary=yes#jcite">Id. at 336-37</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XRI2E7QNB5G0?jcsearch=125%20supreme%20court%202491&amp;summary=yes#jcite">125 S.Ct. 2491</a> (quoting <i>Hopkins v.</i>
<i>Lee</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XJLOFF?jcsearch=19%20us%20109&amp;summary=yes#jcite">19 U.S. (6 Wheat.) 109</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XJLOFF?jcsearch=114&amp;summary=yes#jcite">114</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XJLOFF?jcsearch=5%20l%20ed%20218&amp;summary=yes#jcite">5 L.Ed. 218</a> (1821)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Finality is fundamental to the Rule of Law. In <i>Southern</i>
<i>Pacific Railroad v. United States</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BIK0?jcsearch=168%20us%201&amp;summary=yes#jcite">168 U.S. 1</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BIK0?jcsearch=18%20supreme%20court%2018&amp;summary=yes#jcite">18 S.Ct. 18</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BIK0?jcsearch=42%20l%20ed%20355&amp;summary=yes#jcite">42 L.Ed. 355</a> (1897) the Court stressed the importance of
repose and conclusiveness following upon judicial decision:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This general rule is demanded by the very object for
  which civil courts have been established, which is to
  secure the peace and repose of society by the
  settlement of matters capable of judicial
  determination. Its enforcement is essential to the
  maintenance of social order; for the aid of judicial
  tribunals would not be invoked for the vindication of
  rights of person and property if, as between parties
  and their privies, conclusiveness did not attend the
  judgments of such tribunals in respect of all matters
  properly <span CLASS="page_no" data-cite="102 uspq 2d 1935" data-cite-type="ReporterOfDecisions" data-cite-pageno="1935" data-primary-citation="102 U.S.P.Q.2d 1925">[**1935]</span> put in issue, and actually determined by
  them.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BIK0?jcsearch=168%20U.S.%201&amp;summary=yes#jcite">Id. at 49</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BIK0?jcsearch=18%20supreme%20court%2018&amp;summary=yes#jcite">18 S.Ct. 18</a>. All departments of government
are bound by the finality of the judicial ruling. "Judgments,
within the powers vested in courts by the Judiciary Article of
the Constitution, may not lawfully be revised, overturned or
refused faith and credit by another Department of Government."
<i>Chi &amp; S. Air Lines, Inc. v. Waterman S.S. Corp.</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C19S?jcsearch=333%20us%20103&amp;summary=yes#jcite">333 U.S. 103</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C19S?jcsearch=333%20us%20103&amp;summary=yes#jcite">114</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C19S?jcsearch=68%20supreme%20court%20431&amp;summary=yes#jcite">68 S.Ct. 431</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C19S?jcsearch=92%20l%20ed%20568&amp;summary=yes#jcite">92 L.Ed. 568</a> (1948).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Plant v. Spendthrift Farm, Inc.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2N796?jcsearch=514%20us%20211&amp;summary=yes#jcite">514 U.S. 211</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2N796?jcsearch=115%20supreme%20court%201447&amp;summary=yes#jcite">115 S.Ct. 1447</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2N796?jcsearch=131%20l%20ed%202d%20328&amp;summary=yes#jcite">131 L.Ed.2d 328</a> (1995) the Court traced the
finality of judicial rulings in relation to the executive
branch to <i>Hayburn's Case</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XJLRGB?jcsearch=2%20us%20409&amp;summary=yes#jcite">2 U.S. (2 Dall.) 409</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/XJLRGB?jcsearch=1%20l%20ed%20436&amp;summary=yes#jcite">1 L.Ed. 436</a> (1792), which "stands for the principle that Congress
cannot vest review of the decisions of Article III courts in
officials of the Executive Branch." <i>Plant</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2N796?jcsearch=514%20us%20211&amp;summary=yes#jcite">514 U.S. at 218</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2N796?jcsearch=115%20supreme%20court%201447&amp;summary=yes#jcite">115 S.Ct. 1447</a>. The Court explained:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The record of history shows that the Framers crafted
  this charter of the judicial department with an
  expressed understanding: that it gives the Federal
  Judiciary the power, not merely to rule on cases, but
  to <i>decide</i> them, subject to review only by
  superior courts in the Article III hierarchy &mdash;
  with an understanding, in short, that "a judgment
  conclusively resolves the case" because "a `Judicial
  Power' is one to render dispositive judgments."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i></i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2N796?jcsearch=514%20U.S.%20211&amp;summary=yes#jcite">Id. at 218-19</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2N796?jcsearch=115%20supreme%20court%201447&amp;summary=yes#jcite">115 S.Ct. 1447</a> (quoting Frank H.
Easterbrook, <i>Presidential Review</i>,
<cite>40 Case W. Res. L. Rev. 905</cite>, 926 (1990)) (emphasis in original). In <i>Town of</i>
<i>Deerfield v. Federal Communications Commission</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X4AP3H?jcsearch=992%20f%202d%20420&amp;summary=yes#jcite">992 F.2d 420</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X4AP3H?jcsearch=992%20f%202d%20420&amp;summary=yes#jcite">428</a> (2d Cir. 1993), the court elaborated that revision by
the FCC of the court's order would render the court's previous
judgment merely advisory, and thus in violation of the
Constitution.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Yet this court continues to authorize the Patent and Trademark
Office to "revise, overturn, and refuse full faith and credit"
to final judgments of the courts, in the words of <i>Chicago</i>
<i>&amp; Southern Air Lines</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C19S?jcsearch=333%20us%20103&amp;summary=yes#jcite">333 U.S. at 114</a>. Such agency
action has not been authorized by any other court. To the
contrary, when the judicial decision is final as to the issue
before the agency, the decision is binding on the agency.
Finality is reflected in the law of the case doctrine, which
"promotes the finality and efficiency of the judicial process
by protecting against the agitation <span CLASS="page_no" data-cite="2012 bl 121025 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[***11]</span> of settled issues."
<i>Christianson v. Colt Industries Operating Corp.</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CBKE?jcsearch=486%20us%20800&amp;summary=yes#jcite">486 U.S. 800</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CBKE?jcsearch=486%20us%20800&amp;summary=yes#jcite">815-16</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CBKE?jcsearch=108%20supreme%20court%202166&amp;summary=yes#jcite">108 S.Ct. 2166</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CBKE?jcsearch=100%20l%20ed%202d%20811&amp;summary=yes#jcite">100 L.Ed.2d 811</a> (1988). This
universal doctrine in not new to the Federal Circuit, <i>see,</i>
<i>e.g., Suel v. Secretary of Health &amp; Human Services</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X36DHO?jcsearch=192%20f%203d%20981&amp;summary=yes#jcite">192 F.3d 981</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X36DHO?jcsearch=192%20f%203d%20981&amp;summary=yes#jcite">984-85</a> (Fed. Cir. 1999) (The law of the case
doctrine "ensures judicial efficiency and prevents endless
litigation. Its elementary logic is matched by elementary
fairness &mdash; a litigant given one good bite at the apple
should not have a second."); <i>Perkin-Elmer Corp. v.</i>
<i>Computer-vision Corp.</i>,
<span CLASS="page_no" data-cite="678 f 3d 1368" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1368" data-primary-citation="678 F.3d 1357">[*1368]</span> 
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X4A66Q?jcsearch=732%20f%202d%20888&amp;summary=yes#jcite">732 F.2d 888</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X4A66Q?jcsearch=732%20f%202d%20888&amp;summary=yes#jcite">900</a> (Fed. Cir. 1984) (the law of the case doctrine
is designed to put an end to issues that have been fully
litigated and resolved).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The theories of preclusion implement the fundamentals of
judicial finality, for a final judicial determination controls
the issue in all forums. <i>See Federated Dep't Stores, Inc.</i>
<i>v. Moitie</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA5A?jcsearch=452%20us%20394&amp;summary=yes#jcite">452 U.S. 394</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA5A?jcsearch=452%20us%20394&amp;summary=yes#jcite">401</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA5A?jcsearch=101%20supreme%20court%202424&amp;summary=yes#jcite">101 S.Ct. 2424</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA5A?jcsearch=69%20l%20ed%202d%20103&amp;summary=yes#jcite">69 L.Ed.2d 103</a> (1981) ("This Court has long recognized that [p]ublic
policy dictates that there be an end of litigation; that those
who have contested an issue shall be bound by the result of the
contest, and that matters once tried shall be considered
forever settled as between the parties.'") (quoting <i>Baldwin</i>
<i>v. Traveling Men's Ass'n</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BUEA?jcsearch=283%20us%20522&amp;summary=yes#jcite">283 U.S. 522</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BUEA?jcsearch=283%20us%20522&amp;summary=yes#jcite">525</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BUEA?jcsearch=51%20supreme%20court%20517&amp;summary=yes#jcite">51 S.Ct. 517</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5BUEA?jcsearch=75%20l%20ed%201244&amp;summary=yes#jcite">75 L.Ed. 1244</a> (1931)). In <i>Allen v. McCurry</i>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA2N?jcsearch=449%20us%2090&amp;summary=yes#jcite">449 U.S. 90</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA2N?jcsearch=449%20us%2090&amp;summary=yes#jcite">94</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA2N?jcsearch=101%20supreme%20court%20411&amp;summary=yes#jcite">101 S.Ct. 411</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CA2N?jcsearch=66%20l%20ed%202d%20308&amp;summary=yes#jcite">66 L.Ed.2d 308</a> (1980) the Court
explained that "res judicata and collateral estoppel relieve
parties of the cost and vexation of multiple lawsuits, conserve
judicial resources, and, by preventing inconsistent decisions,
encourage reliance on adjudication." Applying these principles
to patent reexamination of the same issues of fact and law as
were decided in judicial proceedings, the principles of
preclusion apply. A patent that has been adjudicated to be
valid cannot be invalidated by administrative action, any more
than a patent adjudicated to be invalid can be restored to life
by administrative action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In enacting the various reexamination statutes, Congress did
not purport to violate the constitutional strictures governing
finality of judicial process. The possibilities for vexation
and abuse were perceived from the initiation of reexamination;
when the first reexamination statute was proposed, Patent
Commissioner Diamond testified that the statute contained
various safeguards and "carefully protects patent owners from
reexamination proceedings brought for harassment or spite. The
possibility of harassing patent owners is a classic criticism
of some foreign reexamination systems and we made sure it would
not happen here." Hearings on H.R. 6933, 6934, <span CLASS="page_no" data-cite="102 uspq 2d 1936" data-cite-type="ReporterOfDecisions" data-cite-pageno="1936" data-primary-citation="102 U.S.P.Q.2d 1925">[**1936]</span> 3806 &amp; 215,
<i>Industrial Innovation &amp; Patent &amp; Copyright Law</i>
<i>Amendments</i>, House Comm. on the Judiciary, 96th Cong.,
2d Sess. 594 (1980). Nonetheless, commentators were skeptical; for
example, Anthony H. Handal, <i>Reexamination: Some Tactical</i>
<i>Considerations</i> &mdash; <i>A Private Practitioner's</i>
<i>Viewpoint</i>, 9 AIPLA Q.J. 249 (1981), explained that
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  a party threatened with litigation has the opportunity
  to file reexamination requests on the patents
  concerned, or without doing anything, has the threat
  of such action to use in any negotiation which may be
  in progress. Likewise, a threatened party also has the
  opportunity of putting a number of patents into
  reexamination which are not even related to the
  <span CLASS="page_no" data-cite="2012 bl 121025 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[***12]</span> subject matter of the threat. Thus, even where the
  party threatened with litigation is in a relatively
  weak position with respect to the asserted patents, he
  can very viably threaten to retaliate against the
  patent owner by counter-attacking where the patent
  owner is in a relatively weak position.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i>Id.</i> at 251. When reexamination was later enlarged, an
article by William J. Speranza and Michael L. Goldman,
<i>Reexamination</i> &mdash; <i>The Patent Challenger's</i>
<i>View</i>, 69 J. Pat. &amp; Trademark Off. Soc'y 295 (1987)
remarked that reexamination "has potential for misuse by the
patent challenger to achieve less-than-noble aims, such as
delay or harassment, in an effort to escape liability where no
legitimate defense exists." <i></i><cite>Id. at 296</cite>.<a HREF="#fn100" name="fnref_fn100">[fn1]</a>
<span CLASS="page_no" data-cite="678 f 3d 1369" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1369" data-primary-citation="678 F.3d 1357">[*1369]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Today, reexamination is part of the tactical armory of
litigators. However, throughout this history, including the
current legislative proposals to make reexamination more useful
as a less costly alternative to litigation, we have uncovered
no suggestion that reexamination is intended to deprive a final
judgment of the full faith and credit attendant upon final
judgments. We have found no hint that reexamination of the
question of patentability is intended to override judicial
resolution of the question of patentability. Nor would such
legislation be contemplated, for "Article III, <cite>&sect; 1</cite>
safeguards the role of the Judicial Branch in our tripartite
system by barring congressional attempts `to transfer
jurisdiction [to non-Article III tribunals] for the purpose of
emasculating' constitutional courts, and thereby preventing
`the encroachment or aggrandizement of one branch at the
expense of the other.'" <i>Commodity Futures Trading Comm'n v.</i>
<i>Schor</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2NU13?jcsearch=478%20us%20833&amp;summary=yes#jcite">478 U.S. 833</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2NU13?jcsearch=478%20us%20833&amp;summary=yes#jcite">850</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2NU13?jcsearch=106%20supreme%20court%203245&amp;summary=yes#jcite">106 S.Ct. 3245</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2NU13?jcsearch=92%20l%20ed%202d%20675&amp;summary=yes#jcite">92 L.Ed.2d 675</a>
(1986) (brackets in original, citations omitted). The Court
stressed that "Article III, &sect; 1, not only preserves to
litigants their interest in an impartial and independent
federal adjudication of claims within the judicial power of the
United States, but also serves as `an inseparable element of
the constitutional system of checks and balances.'"
<i><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2NU13?jcsearch=478%20U.S.%20833&amp;summary=yes#jcite">Id</a>.</i> (quoting <i>N. Pipeline Constr. Co. v. Marathon</i>
<i>Pipe Line Co.</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CAB8?jcsearch=458%20us%2050&amp;summary=yes#jcite">458 U.S. 50</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CAB8?jcsearch=458%20us%2050&amp;summary=yes#jcite">58</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CAB8?jcsearch=102%20supreme%20court%202858&amp;summary=yes#jcite">102 S.Ct. 2858</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CAB8?jcsearch=73%20l%20ed%202d%20598&amp;summary=yes#jcite">73 L.Ed.2d 598</a> (1982)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Administrative agency override of judicial final decisions has
no counterpart in any other field of subject matter. From the
inception of judicial process in the nation, it was established
that decisions of Article III courts are not subject to
negation by proceedings in the other branches. The validity of
the Baxter patent was resolved upon litigation in the district
court and on appeal to the Federal Circuit. This judgment
cannot be "revised, overturned or refused full faith and credit
by another Department of Government." <i>Chi &amp; S. Air</i>
<i>Lines</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C19S?jcsearch=333%20us%20103&amp;summary=yes#jcite">333 U.S. at 114</a>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5C19S?jcsearch=68%20supreme%20court%20431&amp;summary=yes#jcite">68 S.Ct. 431</a>. Nonetheless, the
court again departs from this principle, trivializes our prior
final judgment, and simply defers to the conflicting agency
ruling. This is improper.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  I support the concept of reexamination as an efficient and
economical alternative to litigation in appropriate cases. My
concern is with the distortion of this purpose, which was
designed to provide a path to relief not available through the
existing examination process. <span CLASS="page_no" data-cite="2012 bl 121025 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[***13]</span> It was not intended to undermine
the finality of judicial process; it was not intended to negate
the repose provided by adjudication.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The only patents that are reexamined, like the only patents
that are litigated, are patents on inventions that are of
value. Most reexamination requests are granted by the PTO.<a HREF="#fn200" name="fnref_fn200">[fn2]</a>
Reexamination <span CLASS="page_no" data-cite="102 uspq 2d 1937" data-cite-type="ReporterOfDecisions" data-cite-pageno="1937" data-primary-citation="102 U.S.P.Q.2d 1925">[**1937]</span> of the Baxter patent was requested by Fresenius
in 2005, two years into the litigation of Fresenius'
declaratory judgment action against Baxter. The reexamination
request presented to the PTO the same references that Fresenius
had presented in
<span CLASS="page_no" data-cite="678 f 3d 1370" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1370" data-primary-citation="678 F.3d 1357">[*1370]</span> 
the litigation. Judgment in the district court was adverse
to Fresenius, and the Federal Circuit's final judgment was
issued in 2009, a year before the reexamination decision of the
PTO Board. The Board stated that "the agency is not bound by
the court's determination." BPAI Op. at 26. However, when there
has been full litigation and final adjudication under
Article III, the judicial resolution controls. Instead, my colleagues
ignore this court's prior decision, which is the law of this
case, and simply defer to the PTO, stating that its
reexamination ruling is "supported by substantial evidence."
Op. at 11-13 &amp; 16. The nature of the burden of proof does
not overcome the strictures of judicial finality.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The reexamination of Baxter's patent claims 26-29 and 31 was
based solely on the same references on which Fresenius relied
in the litigation. In response to the panel's request during
oral argument, Baxter's counsel wrote that "all of the
art relied upon by the Examiner to reject claims 26-29 and 31 of
the &prime;<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X2GGGE41H0J?jcsearch=usp%205247434&amp;summary=yes#jcite">434 patent</a> (<i>i.e.</i>, Lichtenstein &prime;983,
the Fresenius CMS08 Handbook, the Sarns 9000 Perfusion System
Operators Manual, Rubalcaba &prime;578, and Kerns &prime;706,
<i>see</i> A9283) had been presented by Fresenius to the
district court," Letter from William F. Lee (February 22,
2012). The PTO Deputy Solicitor wrote that "The Examiner only
found Thompson," Letter from Sydney O. Johnson, Jr. (February
17, 2012); the Thompson reference was cited only against claim
30, for showing the inclusion of an anticoagulant in the
dialysis. This aspect does not appear to be significant to the
reexamination, but if it were, the failure of Fresenius to
present such issue does not negate the finality of the decision
upon full adjudication. <i>See</i> Charles Alan Wright,
Arthur R. Miller &amp; Edward H. Cooper, <i>Federal Practice</i>
<i>and Procedure: Jurisdiction</i>, <cite>&sect; 4426</cite> at 141 (1981)
("Preclusion cannot be avoided simply by offering evidence in
the second proceeding that could have been admitted, but was
not, in the first."). Reexamination of the Baxter patent lasted
from 2005 to 2010, continuing for a year after final decision
in the Federal Circuit.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  My colleagues justify the PTO's authority to overrule judicial
decisions on the argument that the standard of proof is
different in the PTO than in the courts. That theory is flawed,
for obviousness is a question of law, and the PTO, like the
court, is required to reach the correct conclusion on correct
law. Any distinction between judicial and agency procedures
cannot authorize the agency to overrule a final judicial
<span CLASS="page_no" data-cite="2012 bl 121025 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[***14]</span> decision. Even if the Federal Circuit were believed to have
erred in its prior decision, the mechanism for correcting an
unjust decision is by judicial reopening, not by administrative
disregard. <i>See Christianson</i>, <a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CBKE?jcsearch=486%20us%20800&amp;summary=yes#jcite">486 U.S. at 817</a>,
<a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X5CBKE?jcsearch=108%20supreme%20court%202166&amp;summary=yes#jcite">108 S.Ct. 2166</a> ("A court has the power to revisit prior decisions
of its own or of a coordinate court in any circumstance,
although as a rule courts should be loath to do so in the
absence of extraordinary circumstances such as where the
initial decision was clearly erroneous and would work a
manifest injustice."). This procedure did not occur in this
case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The court's final judgment cannot be overridden by
administrative proceeding. I respectfully dissent.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> A significant number of patents in litigation are also
subject to reexamination. USPTO Reexamination Filing Data
&mdash; September 30, 2011, http://www.uspto.gov/patents/stats/
index.jsp (70% of patents undergoing inter partes reexamination
and <i>33%</i> of patents undergoing ex partes reexaminations
are known to be in litigation). It is reported that 11% of
patents accepted for reexamination by the USPTO are reexamined
more than once, one as many as six times. Robert G. Sterne
<i>et ah, Reexamination Practice with Concurrent District</i>
<i>Court Litigation or <cite>Section 337</cite> USITC Investigations</i>,
11 Sedona Conf. J. 14 (Sept. 2010).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> The PTO reports that in 2007 through 2011 the percentage
of reexamination requests granted was 97.1% in FY2007; 94.0% in
FY2008; 93.5% in FY2009; 91.7% in FY2010; and 89.3% in F-2011.
<i>USPTO Performance and Accountability Report for Fiscal Year</i>
<i>2011</i>, Table 14A at 171, http://www.uspto.gov/
about/stratplan/ar/index.jsp. The report does not distinguish
whether the requests were filed by the patentee or by a third
party.
</p></div>
<!--BBLS DD 1709533298691-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HO420003/history">Direct History (44)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HO420003/analysis">Case Analysis (9)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1HO420003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
9
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Order Affirmed</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Medical Devices</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/document/X1Q6LFIDGO82">11-01073 (Fed. Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Civil Procedure</div><div class='facetItemLabel'>Copyright Law</div><div class='facetItemLabel'>Patent Law</div><div class='facetItemLabel'>Trademark Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/f5e429a1cda65302a0d16c1e6b109ae0/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "f5e429a1cda65302a0d16c1e6b109ae0";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY64495b&previousPageId=&previousActivityInstanceId=ENTITY98df16&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:47:45-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1HO420003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY98df16&previousPageId=&previousActivityInstanceId=ENTITY21b48c&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:47:41-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1HO420003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1HO420003";
$('#page_loader').show().spin();
JUDGE_IDS=["15753020","1718421","1850676"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
